Drugs / bibrocathol
bibrocathol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01357538 Comparator | Feb → Jul 2009 | blepharitis | Ursapharm Arzneimittel GmbH | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bibrocathol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01357538 ↗ |
| Known as | Bibrocatol | ChEMBL registry synonym — accepted as the source's own label CHEMBL44875 ↗ |
| Known as | Noviform | ChEMBL registry synonym — accepted as the source's own label CHEMBL44875 ↗ |
| Known as | Posiformin 2 % | “Posiformin 2 %, bibrocathol” NCT01357538 ↗ |
| Modality | Small molecule | — CHEMBL44875 ↗ |
| Route | Topical | “eye ointment applied to the eye lid” NCT01357538 ↗ |